Thursday, August 20, 2009

Does the Combination of Aricept and Namenda Help Slow the Rate of Decline in Alzheimer's Patients

My name is Bob DeMarco, I am an Alzheimer's caregiver. My mother Dorothy, now 93 years old, suffers from Alzheimer's disease.

A year ago, my mother's Alzheimer's disease started to worsen. As a result, I was both concerned and worried.

At the same time, I read a new research study about the combination of Aricept and Namenda as a treatment for Alzheimer's disease.
"The results of this study should change the way we treat patients with Alzheimer's disease. Cholinesterase inhibitors are approved for use in mild to moderate dementia, while memantine has been approved for advanced dementia. But it looks like there is an advantage in prescribing both drugs as initial treatment."--John Growdon, MD

The results of the research study indicated that the combination of Aricept and Namenda helped slow the rate of decline in Alzheimer's patients.

To continue reading go here.

Original content the Alzheimer's Reading Room.


The Complete Eldercare Planner, Revised and Updated Edition: Where to Start, Which Questions to Ask, and How to Find Help

Wednesday, August 12, 2009

Thursday, August 6, 2009

(R)evolution in Alzheimers Related Caregiving

Follow the Alzheimer's Reading Room link to continue reading
One of my greatest fears is the day I might have to place my mother in an Alzheimer's care facility. I say might because I pray that I'll never have to do it.
I receive emails all the time from people that experience the guilt, angst, and remorse of having place their loved one in a Alzheimer's care facility that provides little care, and is a horrid environment for their loved one.
It doesn't have to be that way...........
Perhaps what’s going on here is actually miraculous: nearly every one of them has been liberated from the nightmare of antipsychotic drugs. And virtually all of them will never be readmitted to a hospital behavior unit, a nursing home--or shackled to a restraint and left alone to die.--Laurence Harmon, et al
 blog it